AXA Investment Managers’s Procept Biorobotics PRCT Stock Holding History

AXA Investment Managers’s Portfolio PRCT Stock Details PRCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$39.6M	Buy	+1,109,870	New	+$50.7M	0.11%	169

Other funds holding PRCT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

AXA Investment Managers's PRCT Position: Q3 2025 in Review

AXA Investment Managers opened a new position in Procept Biorobotics (PRCT) in Q3 2025: 1,109,870 shares worth $39.6M. The stake represents 0.11% of the portfolio and ranks #169 among its holdings.

242 funds tracked by Wall St. Rank hold PRCT as of Q3 2025.

AXA Investment Managers held 1,109,870 shares of Procept Biorobotics worth $39.6M as of Q3 2025.
Procept Biorobotics was a new AXA Investment Managers position in Q3 2025.
Procept Biorobotics made up 0.11% of AXA Investment Managers's portfolio in Q3 2025, its #169 holding.
242 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2025.

Based on AXA Investment Managers's 13F filing for Q3 2025, filed 14 Nov 2025.